JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Scope & Guideline

Empowering professionals with pivotal research and knowledge.

Introduction

Welcome to your portal for understanding JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0022-3050
PublisherBMJ PUBLISHING GROUP
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1920 to 1937, from 1945 to 2024
AbbreviationJ NEUROL NEUROSUR PS / J. Neurol. Neurosurg. Psychiatry
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND

Aims and Scopes

The 'Journal of Neurology, Neurosurgery and Psychiatry' focuses on the latest research and clinical advances in neurology, neurosurgery, and psychiatry. It aims to provide a platform for sharing knowledge and disseminating findings that impact patient care and treatment methodologies.
  1. Neuroscience and Neurodegenerative Disorders:
    The journal covers a broad range of topics in neuroscience including the pathophysiology, diagnosis, and treatment of neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS).
  2. Neuropsychiatry and Behavioral Neurology:
    Research in this area explores the intersection of neurological and psychiatric conditions, including studies on cognitive decline, mood disorders, and the impact of neurological conditions on mental health.
  3. Clinical Trials and Therapeutics:
    The journal publishes findings from clinical trials that assess new therapies and interventions for neurological and psychiatric disorders, emphasizing evidence-based practices.
  4. Neuroimaging and Biomarkers:
    There is a strong focus on neuroimaging studies and the identification of biomarkers that can aid in the diagnosis and monitoring of various neurological disorders.
  5. Functional Neurology and Rehabilitation:
    The scope includes research on functional neurological disorders and rehabilitation strategies aimed at improving patient outcomes and quality of life.
  6. Epidemiology and Public Health in Neurology:
    The journal addresses the epidemiological aspects of neurological disorders, including risk factors, prevalence, and the socio-economic impact of these conditions.
The journal is currently witnessing a rise in interest in several emerging themes that reflect the changing landscape of neurological and psychiatric research. These trends indicate areas of growing importance and innovation.
  1. Neuroinflammation and Immune-mediated Disorders:
    Research focusing on the role of neuroinflammation and immune responses in neurological disorders is gaining momentum, particularly in light of findings related to COVID-19 and its neurological implications.
  2. Genetic and Biomolecular Studies:
    There is an increasing emphasis on genetic studies and biomolecular markers that can aid in understanding the pathogenesis of disorders like ALS and frontotemporal dementia, as well as personalized medicine approaches.
  3. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has accelerated the adoption of telemedicine and remote monitoring solutions in neurology, leading to a surge in studies evaluating their effectiveness and patient satisfaction.
  4. Functional Neurological Disorders:
    An emerging focus on functional neurological disorders is evident, with more research dedicated to understanding their mechanisms, assessment, and management strategies.
  5. Cognitive and Behavioral Interventions:
    There is a growing interest in cognitive rehabilitation and behavioral interventions, particularly in dementia and neurodegenerative diseases, highlighting the importance of multidisciplinary approaches to patient care.

Declining or Waning

As the field of neurology and psychiatry evolves, certain research themes have shown a decline in prominence. These waning scopes may reflect shifting priorities in research funding, clinical practice, or public health focus.
  1. Traditional Psychopharmacology:
    There appears to be a decreasing emphasis on traditional psychopharmacological studies, as newer therapeutic approaches and integrative strategies gain traction in treating psychiatric disorders.
  2. Classical Neurological Assessments:
    Standardized neurological assessments that have been historically used may be gradually replaced by more sophisticated, technology-driven approaches, leading to less frequent publications on traditional methods.
  3. Single Disease Focus Studies:
    Research focusing exclusively on single disease entities without considering comorbidities or broader neurological interactions seems to be declining, as there is an increasing recognition of the complexity of neurological disorders.
  4. Basic Science Research:
    There is a noticeable trend away from purely basic science research in neurology towards more translational and clinical studies that directly impact patient care.

Similar Journals

Current Treatment Options in Neurology

Pioneering the Path to Effective Neurological Treatments
Publisher: CURRENT MEDICINE GROUPISSN: 1092-8480Frequency: 12 issues/year

Current Treatment Options in Neurology, published by CURRENT MEDICINE GROUP, is a pivotal journal in the field of clinical neurology, dedicated to enhancing the understanding and management of neurological disorders. With a print ISSN of 1092-8480 and an E-ISSN of 1534-3138, this journal serves as a vital resource for clinicians, researchers, and students alike, providing evidence-based insights and treatment strategies from its continuous publication since its inception in 1999. It currently holds a respectable rank in the Q3 quartile, reflecting its competitive standing in the Scopus rankings for clinical neurology, placing it at the 51st percentile. Although not classified as Open Access, the journal continues to provide valuable contributions that inform clinical practices and improve patient outcomes in neurological care. With its comprehensive reviews and clinical focus, Current Treatment Options in Neurology remains an essential platform for disseminating the latest advancements in treatment methodologies and therapeutic options, solidifying its importance in the ever-evolving landscape of neurology.

NEUROLOGY

Unveiling the latest innovations in brain health.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0028-3878Frequency: 48 issues/year

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

BMC Neurology

Empowering Researchers to Transform Neurological Care
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Neurology is a prominent open-access journal dedicated to advancing the field of neurology and related medical disciplines. Published by BMC since 2001, this journal serves as a vital platform for researchers and clinicians to disseminate their findings in a rapidly evolving area of study. With an impact factor reflecting its importance, BMC Neurology holds a commendable Q2 ranking in both Medicine (miscellaneous) and Clinical Neurology categories, situating it among the top-tier journals in its field. The journal, based in the United Kingdom, covers a wide range of topics pertaining to neurological diseases, treatment methodologies, and advancements in neuroscience. This rigorous publication prioritizes *original research articles, reviews, and clinical studies*, offering researchers and professionals easy access to cutting-edge insights and innovative approaches. As a valuable resource for students, healthcare professionals, and academicians alike, BMC Neurology is committed to fostering knowledge and collaboration in the pursuit of improved neurological health.

JAMA Neurology

Empowering Clinicians with Cutting-Edge Neurological Knowledge
Publisher: AMER MEDICAL ASSOCISSN: 2168-6149Frequency: 12 issues/year

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

EUROPEAN NEUROLOGY

Exploring Neurological Innovations Since 1897
Publisher: KARGERISSN: 0014-3022Frequency: 6 issues/year

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.

NEUROLOGIA

Empowering Minds: The Open Access to Neurological Research
Publisher: ELSEVIER ESPANA SLUISSN: 0213-4853Frequency: 9 issues/year

NEUROLOGIA, an esteemed journal published by ELSEVIER ESPANA SLU, stands at the forefront of the field of neurology, with a dedicated focus on innovative research and clinical practice since its inception in 1973. As an Open Access journal since 2017, it champions the dissemination of knowledge, allowing researchers, professionals, and students alike to access cutting-edge findings in neurology without barriers. With an impressive Scopus rank of #115 in the clinical neurology category, placing it in the 71st percentile, NEUROLOGIA is categorized as Q3 in both general medicine and clinical neurology, reflecting its impact and relevance in a rapidly evolving field. Based in Barcelona, Spain, the journal's commitment to advancing understanding of neurological conditions is underscored by its rigorous peer-review process and engagement with a global audience. As it continues to publish vital research that shapes clinical practices and informs policy, NEUROLOGIA remains an integral resource for those striving to improve outcomes in neurology.

LANCET NEUROLOGY

Shaping the Future of Neurological Care
Publisher: ELSEVIER SCIENCE INCISSN: 1474-4422Frequency: 12 issues/year

The Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.

NEUROLOGIA MEDICO-CHIRURGICA

Bridging Disciplines for Innovative Medical Insights
Publisher: JAPAN NEUROSURGICAL SOCISSN: 0470-8105Frequency: 12 issues/year

NEUROLOGIA MEDICO-CHIRURGICA, published by the JAPAN NEUROSURGICAL SOCIETY, stands as a vital resource in the fields of neurology and surgery, featuring an impressive track record since its inception in 1959. With both an ISSN 0470-8105 and E-ISSN 1349-8029, this journal has embraced an Open Access model since 2000, ensuring that cutting-edge research and clinical advances are readily accessible to a global audience. The journal is currently ranked in the Q2 quartile for Neurology (clinical) and the prestigious Q1 quartile for Surgery as of 2023, highlighting its impact within these disciplines. With Scopus rankings placing it at #145 in Surgery and #206 in Neurology, NEUROLOGIA MEDICO-CHIRURGICA continues to play a crucial role in advancing medical knowledge, making it an indispensable reference for researchers, clinicians, and students alike. The journal's broad scope encompasses both clinical neurology and surgical techniques, positioning it at the forefront of interdisciplinary collaboration in the ever-evolving field of neurosurgery.

Annals of Clinical and Translational Neurology

Connecting Science and Medicine in Neurology
Publisher: WILEYISSN: 2328-9503Frequency: 12 issues/year

Annals of Clinical and Translational Neurology is a premier journal published by WILEY, focusing on the fields of neurology and neuroscience. Since its inception in 2014, it has established itself as an Open Access platform, providing unrestricted access to cutting-edge research to promote scientific collaboration and innovation. With an impressive Impact Factor residing in the top quartile (Q1) for both clinical neurology and miscellaneous neuroscience in 2023, this journal ranks #52 out of 400 in the Neurology category and #22 out of 113 in General Neuroscience, indicating its significant contribution to the field. The journal welcomes submissions that address emerging trends and challenges in translational neurology, aiming to bridge the gap between laboratory research and clinical practice. By disseminating high-quality research and fostering a community of scholars, Annals of Clinical and Translational Neurology plays a vital role in advancing our understanding of neurological disorders and improving patient care worldwide.

BMJ Neurology Open

Advancing neurology through open-access research.
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Neurology Open is an esteemed, peer-reviewed open-access journal published by the BMJ Publishing Group, focusing exclusively on advancements in the field of neurology. Launched in 2019, this journal has quickly positioned itself as a valuable resource within the neurology community, boasting a Q2 ranking in both neurology and clinical neurology categories in 2023. The journal emphasizes the dissemination of high-quality research, clinical studies, and reviews that address critical issues and emerging trends in neurology. With its open-access model, BMJ Neurology Open ensures that cutting-edge findings are readily available to researchers, healthcare professionals, and students across the globe, promoting knowledge sharing and collaboration within this vital discipline. The journal welcomes submissions that contribute to the understanding of neurological disorders and their management, thereby fostering advancements in both research and clinical practice.